<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR2">
 <label>2.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ford</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Migone</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Calmy</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Kerschberger</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Kanters</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Nsanzimana</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Mills</surname>
    <given-names>EJ</given-names>
   </name>
   <name>
    <surname>Meintjes</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Vitoria</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Doherty</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Shubber</surname>
    <given-names>Z</given-names>
   </name>
  </person-group>
  <article-title>Benefits and risks of rapid initiation of antiretroviral therapy</article-title>
  <source>AIDS</source>
  <year>2018</year>
  <volume>32</volume>
  <issue>1</issue>
  <fpage>17</fpage>
  <lpage>23</lpage>
  <pub-id pub-id-type="doi">10.1097/QAD.0000000000001671</pub-id>
  <pub-id pub-id-type="pmid">29112073</pub-id>
 </element-citation>
</ref>
